Desentum Oy
PrivateLast Round
VC Round
Apr 27, 2026
Total Funding Raised
$28.9M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Desentum Oy is a clinical-stage biopharmaceutical company that develops novel allergen immunotherapy products designed to switch the immune system's response to allergens from hypersensitivity to tolerance.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Desentum Oy Comparables
Compare Desentum Oy with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Angany | 81% | |
| Aravax | 81% | |
| Mabylon AG | 78% | |
Desentum Oy Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Apr 27, 2026 | ||||
| Series C | Feb 20, 2024 | ||||
| Series A | Jan 21, 2022 | ||||
| VC Round | Nov 1, 2019 | ||||
| Grant | Oct 29, 2018 | ||||
Crowdfunding | Nov 29, 2017 |
Desentum Oy Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cascara Ventures | Series A |
| VTT Holding | Series A |
| European Innovation Council Fund | Grant |
| Springvest | VC Round, Series A, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 27, 2026
$21.15M round led by Springvest
- Jul 18, 2025
Grew 33% QoQ from 9 to 12 employees.
Desentum Oy Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Desentum Oy's valuation, stock price, and market status.